Innovation Pharmaceuticals Inc (IPIX)

[petemantx]

Otezla is currently on target to be a $2B/yr drug this year. If Prurisol comes out with 40%PASI75 or better, it should wipe out Otezla and become more of a $6-7B/ yr drug IMO and that may even be conservative.

My valuation is based on Prurisol becoming the first choice for treatment if it exceeds 40%+ as it would then be the safest drug on the market by a wide margin, darn near equal to the biologics for efficacy, and I believe (not positive) that it will also be the most inexpensive treatment.

What doctor wouldn't try Prurisol first and if it doesn't work, then go to the more costly and risky treatments?